Bioprocess Containers Market Report by Type (2D Container, 3D Container, Accessories), Application (Production Process, Upstream Process, Downstream Process), End User (Pharmaceutical Companies, Biotechnology Companies), and Region- Forecast till 2027
ID: MRFR/MED/5169-HCR | February 2021 | Region: Global | 100 Pages
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Bioprocess Containers Market, by Type
6.1 Introduction
6.2 2D Container
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 3D Container
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Accessories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Bioprocess Containers Market, by Application
7.1 Introduction
7.2 Production Process
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Upstream Process
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Downstream Process
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Bioprocess Containers Market, by End User
8.1 Introduction
8.2 Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Biotechnology Companies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Other
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Bioprocess Containers Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 GE Healthcare
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Merck KGaA
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Thermo Fisher Scientific
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Sartorius
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Danaher Corporation
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Lonza
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Fenner PLC
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Rim Bio
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Fluids Control
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Meissner
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Bioprocess Containers Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Bioprocess Containers Market Synopsis, 2020-2027
Table 2 Global Bioprocess Containers Market Estimates and Forecast, 2020-2027
(USD Million)
Table 3 Global Bioprocess Containers Market, by Region, 2020-2027 (USD Million)
Table 4 Global Bioprocess Containers Market, by Type, 2020-2027 (USD Million)
Table 5 Global Bioprocess Containers Market, by Application, 2020-2027 (USD Million)
Table 7 Global Bioprocess Containers Market, by End User, 2020-2027 (USD Million)
Table 8 North America: Bioprocess Containers Market, by Type, 2020-2027 (USD Million)
Table 9 North America: Bioprocess Containers Market, by Application, 2020-2027 (USD Million)
Table 10 North America: Bioprocess Containers Market, by End User, 2020-2027
(USD Million)
Table 11 US: Bioprocess Containers Market, by Type, 2020-2027
(USD Million)
Table 12 US: Bioprocess Containers Market, by Application, 2020-2027
(USD Million)
Table 13 US: Bioprocess Containers Market, by End User, 2020-2027 (USD Million)
Table 14 Canada: Bioprocess Containers Market, by Type, 2020-2027 (USD
Million)
Table 15 Canada: Bioprocess Containers Market, by Application, 2020-2027 (USD
Million)
Table 16 Canada: Bioprocess Containers Market, by End User, 2020-2027 (USD
Million)
Table 17 South America: Bioprocess Containers Market, by Type, 2020-2027
(USD Million)
Table 18 South America: Bioprocess Containers Market, by Application, 2020-2027
(USD Million)
Table 19 South America: Bioprocess Containers Market, by End User, 2020-2027
(USD Million)
Table 20 Europe: Bioprocess Containers Market, by Type, 2020-2027 (USD
Million)
Table 21 Europe: Bioprocess Containers Market, by Application, 2020-2027 (USD
Million)
Table 22 Europe: Bioprocess Containers Market, by End User, 2020-2027 (USD
Million)
Table 23 Western Europe: Bioprocess Containers Market, by Type, 2020-2027 (USD Million)
Table 24 Western Europe: Bioprocess Containers Market, by Application, 2020-2027 (USD Million)
Table 25 Western Europe: Bioprocess Containers Market, by End-User, 2020-2027
(USD Million)
Table 26 Eastern Europe: Bioprocess Containers Market, by Type, 2020-2027 (USD Million)
Table 27 Eastern Europe: Bioprocess Containers Market, by Application, 2020-2027
(USD Million)
Table 28 Eastern Europe: Bioprocess Containers Market, by End User, 2020-2027
(USD Million)
Table 29 Asia-Pacific: Bioprocess Containers Market, by Type, 2020-2027
(USD Million)
Table 30 Asia-Pacific: Bioprocess Containers Market, by Application , 2020-2027
(USD Million)
Table 31 Asia-Pacific: Bioprocess Containers Market, by End User, 2020-2027 (USD
Million)
Table 32 Middle East & Africa: Bioprocess Containers Market, by Type,
2020-2027 (USD Million)
Table 33 Middle East & Africa: Bioprocess Containers Market, by Application, 2020-2027 (USD Million)
Table 34 Middle East & Africa: Bioprocess Containers Market, by End User, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Bioprocess Containers Market
Figure 3 Segmentation Market Dynamics for Global Bioprocess Containers Market
Figure 4 Global Bioprocess Containers Market Share, by Type, 2020
Figure 5 Global Bioprocess Containers Market Share, by Application, 2020
Figure 6 Global Bioprocess Containers Market Share, by End User, 2020
Figure 7 Global Bioprocess Containers Market Share, by Region, 2020
Figure 8 North America: Bioprocess Containers Market Share, by Country, 2020
Figure 9 Europe: Bioprocess Containers Market Share, by Country, 2020
Figure 10 Asia-Pacific: Bioprocess Containers Market Share, by Country, 2020
Figure 11 Middle East & Africa: Bioprocess Containers Market Share, by Country, 201
Figure 12 Global Bioprocess Containers Market: Company Share Analysis, 2020 (%)
Figure 13 GE Healthcare: Key Financials
Figure 14 GE Healthcare: Segmental Revenue
Figure 15 GE Healthcare: Geographical Revenue
Figure 16 Merck KGaA: Key Financials
Figure 17 Merck KGaA: Segmental Revenue
Figure 18 Merck KGaA: Geographical Revenue
Figure 19 Thermo Fisher Scientific: Key Financials
Figure 20 Thermo Fisher Scientific: Segmental Revenue
Figure 21 Thermo Fisher Scientific: Geographical Revenue
Figure 22 Sartorius: Key Financials
Figure 23 Sartorius: Segmental Revenue
Figure 24 Sartorius: Geographical Revenue
Figure 25 Danaher Corporation: Key Financials
Figure 26 Danaher Corporation: Segmental Revenue
Figure 27 Danaher Corporation. Geographical Revenue
Figure 28 Lonza: Key Financials
Figure 29 Lonza: Segmental Revenue
Figure 30 Lonza: Geographical Revenue
Figure 31 Fenner PLC: Key Financials
Figure 32 Fenner PLC: Segmental Revenue
Figure 33 Fenner PLC: Geographical Revenue
Figure 34 Rim Bio: Key Financials
Figure 35 Rim Bio: Segmental Revenue
Figure 36 Rim Bio: Geographical Revenue
Figure 37 Fluids Control: Key Financials
Figure 38 Fluids Control: Segmental Revenue
Figure 39 Fluids Control: Geographical Revenue
Figure 40 Meissner: Key Financials
Figure 41 Meissner: Segmental Revenue
Figure 42 Meissner: Geographical Revenue
Bioprocess Containers Market
Bioprocess Containers Market is expected grow USD 9.9 Billion at a CAGR 26.8% during the forecast 2022 - 2030
$9.9 Billion
Market Size
26.8%
CAGR
North America
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- GE Healthcare (US)
- Merck KGaA (Germany)
- Thermo Fisher Scientific (US)
- Sartorius (Germany)
- Danaher Corporation (US)
- Lonza (Switzerland)
- Fenner PLC (UK)
- Rim Bio (US)
- Fluids Control (Argentina)
- Meissner (US)
Drivers
- Lower risk of cross-contamination
- growing demand for biological products
Bioprocess Containers Market Overview
The bioprocess containers market held a valuation of USD 990 million in 2017 and will be progressing at a rate of 13.8% from 2020 to 2027, believes Market Research Future (MRFR).
The surge in single-use technologies has been in response to the surging need for cheaper, faster and better biologics production. Surging introduction of individualized biologics as well as personalized medicines, such as therapeutic vaccines, and patient-specific cellular & gene therapies demands significant sterility. Hence, these are manufactured with the use of single-use equipment as well as consumables. The COVID-19 outbreak resulted in unprecedented need for vaccines. The pandemic has raised the use of laboratory-scale, large-scale single-use bioreactors and consumables like bioprocess containers, filtration assemblies, media bags, and more. In a way, the pandemic has been favorable for the worldwide market.
Over the years, biologics with substantial potency that need lower production volumes, advances in biosimilars that target smaller markets, and ongoing innovations in production yields as well as efficiencies have fostered the utilization of single-use technologies like single-use bioprocess containers since these are apt for small volume productions.
Compared to conventional bio-manufacturing technologies, the single-use systems offer a host of advantages, including reduced need for process validation and more manufacturing flexibility, which leads to better operating efficiency and lower manufacturing costs. Despite these benefits, the possibility of the plastic materials in SUS leaching organic compounds in the processing fluid is a major concern. Such an unwanted change can eventually hamper bioprocessing and have a negative impact on the quality, purity and safety of the final product.
The patent expiry of a number of blockbuster drugs has led to higher R&D expenditure by the biotechnology and pharmaceutical companies. Patent expiry has steered the focus of R&D on biologics, shifting them from pipeline to a more commercial phase. As the production costs of biologics are extremely high, firms are increasingly emphasizing on economical techniques compared to the conventional biomanufacturing methods. Hence, numerous biopharmaceutical developers are making use of single-use bioprocessing technologies in their manufacturing processes.
Market Segmentation
The Bioprocess containers market has been segmented into type, application, and end user.
Based on type, market segmented into the 2D container, 3D container, and accessories. The 2D container segment is expected to account for the largest share of the market in 2017.
Based on application, market segmented into the production process, upstream process, and downstream process. The production process segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.
The market, by end user, has been segmented into pharmaceutical companies, biotech companies, and other.
Market of Bioprocess Containers, by Type
- 2D Container
- 3D Container
- Accessories
Market of Bioprocess Containers, by Application
- Upstream Process
- Downstream Process
- Production Process
Market of Bioprocess Containers, by End User
- Pharmaceutical Companies
- Biotech Companies
- Other End Users
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bioprocess containers market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bioprocess containers market in the Middle East & Africa has been segmented into the Middle East and Africa.
Global Bioprocess Containers Market Share (%), by Region, 2017
Source: Annual Reports, Sec Filings, and Press Release
Regional Market Summary
Geographically, the Americas is anticipated to dominate the bioprocess containers market owing to a well-established player and increasing demand for biological products.
Europe is expected to hold the second largest position in the market.
The bioprocess containers market in the Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the growth in the pharmaceutical and biotech industries.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector.
Key Players
GE Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US) are some of the key players in the bioprocess containers market.
Market of Bioprocess Containers, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
-
Intended Audience
- Bioprocess Containers Manufacturers and vendors
- Various research and consulting firms
- Bioprocess Containers Distributors
Intended Audience
- Bioprocess Containers Manufacturers and vendors
- Various research and consulting firms
- Bioprocess Containers Distributors
Frequently Asked Questions (FAQ) :
The bioprocess containers market is projected to grow at a 13.8% CAGR between 2018-2023.
The Americas is projected to command the largest share in the bioprocess containers market.
Lower risk of cross-contamination and growing demand for biological products are adding market growth.
The 2D container segment will lead the bioprocess containers market.
Biotechnology and pharmaceutical companies are the end users of bioprocess containers market.
